Vivofectamine™ VF232 Liver LNP Composition in Ethanol

Features and benefits

• Optimized formulation for systemic liver delivery
• Delivery efficiency data in vivo benchmarked to ionizable lipids used in leading clinical-stage or FDA-approved drugs
• Safety characterization in vivo
• Flexibility in choice of formulation device and method

Vivofectamine VF232 Liver LNP Composition in Ethanol is a pre-mixed solution with an optimized ratio of an ionizable lipid and helper lipids. It can be used with various formulation devices and methods.

Vivofectamine VF232 Liver LNP Composition in Ethanol is a Research Use Only reagent for use in basic research. For an LNP solution for drug development purposes with a path to clinical and commercial licensing and supply, please submit a contact us request at our Vivofectamine webpage to access our Vivofectamine Delivery Solutions Drug Developers Portfolio.

Vivofectamine VF232 Liver LNP Composition in Ethanol is an animal origin-free product.